Acadian Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,908
| Closed | -$2K | – | 2266 |
|
|
2024
Q3 | $2K | Hold |
10,908
| – | – | ﹤0.01% | 2044 |
|
|
2024
Q2 | $5K | Hold |
10,908
| – | – | ﹤0.01% | 1717 |
|
|
2024
Q1 | $11K | Sell |
10,908
-53,782
| -83% | -$54.2K | ﹤0.01% | 1511 |
|
|
2023
Q4 | $36K | Sell |
64,690
-32,419
| -33% | -$18K | ﹤0.01% | 1504 |
|
|
2023
Q3 | $99K | Sell |
97,109
-70,709
| -42% | -$72.1K | ﹤0.01% | 1307 |
|
|
2023
Q2 | $235K | Buy |
167,818
+71,683
| +75% | +$100K | ﹤0.01% | 1239 |
|
|
2023
Q1 | $151K | Hold |
96,135
| – | – | ﹤0.01% | 1313 |
|
|
2022
Q4 | $139K | Buy |
+96,135
| New | +$139K | ﹤0.01% | 1367 |
|